Gelonhui, March 31, 丨 First Pharmaceutical (600833.SH) announced its 2022 annual report. During the reporting period, it achieved operating income of 2,656 million yuan, an increase of 89.94% over the previous year; net profit attributable to shareholders of listed companies was 144 million yuan, an increase of 190.49% over the previous year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 140 million yuan, an increase of 504.38% over the previous year; and basic earnings per share of 0.64 yuan. It is proposed to distribute a cash dividend of 1.95 yuan (tax included) for every 10 shares to all shareholders.
第一医药(600833.SH)：2022年净利润增长190.49%至1.44亿元 拟10派1.95元
First Pharmaceutical (600833.SH): Net profit increased 190.49% to 144 million yuan in 2022, proposed 10 distribution of 1995 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.